GL Pharm Tech Corp
204840
Company Profile
Business description
GL Pharm Tech Corp is engaged in developing and marketing pharmaceutical products. The company possesses platform formulation technology for drug sustained release, solubilization, stabilization, and enhanced absorption in the colon.
Contact
46 Dalraenae-ro
Seongnam Global Convergence Center B-210
Gyeonggi-do
Sujeong-gu
Seongnam462713
KORT: +82 317395220
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
34
Stocks News & Analysis
stocks
Investors overlooking ASX share’s potential
International expansion is a distraction from valuable local business.
stocks
Cerebras sees blockbuster demand, setting stage for US AI IPO frenzy
The chipmaker’s IPO priced at $185, well above its initial range, and opened trading at an eye-popping $350.
stocks
What did Morningstar subscribers buy and sell in April?
How the most traded shares in April stack up against our analysts views.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,871.30 | 46.00 | -0.52% |
| CAC 40 | 8,082.27 | 0.00 | 0.00% |
| DAX 40 | 24,456.26 | 319.45 | 1.32% |
| Dow JONES (US) | 50,063.46 | 370.26 | 0.75% |
| FTSE 100 | 10,372.93 | 47.58 | 0.46% |
| HKSE | 26,160.03 | 229.01 | -0.87% |
| NASDAQ | 26,635.22 | 232.88 | 0.88% |
| Nikkei 225 | 61,644.75 | 1,009.30 | -1.61% |
| NZX 50 Index | 12,948.00 | 77.07 | -0.59% |
| S&P 500 | 7,501.24 | 56.99 | 0.77% |
| S&P/ASX 200 | 8,631.60 | 41.90 | -0.48% |
| SSE Composite Index | 4,183.06 | 5.14 | 0.12% |